Progression of cognitive dysfunction in elderly chronic kidney disease patients in a veteran's institution in central taiwan: A 3-year longitudinal study

Internal Medicine

Volumn 51, Issue 1, 2012, Pages 29-35

  Weng, Shuo Chun ^a,c   Shu, Kuo Hsiung ^a,b   Tang, Yih Jing ^a,b   Sheu, Wayne Huey Herng ^a   Tarng, Der Cherng ^c,d   Wu, Ming Ju ^a,b,c   Chen, Yi Ming ^a,c   Chuang, Ya Wen ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cognition; Elderly; Estimated glomerular filtration rate

Indexed keywords

APOLIPOPROTEIN E; C REACTIVE PROTEIN; CYSTATIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BLOOD ANALYSIS; CHRONIC KIDNEY DISEASE; CLINICAL DEMENTIA RATING SCALE; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE COURSE; FOLLOW UP; GENETIC POLYMORPHISM; GERIATRIC ASSESSMENT; GERIATRIC DEPRESSION SCALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; LEAN BODY WEIGHT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MINI MENTAL STATE EXAMINATION; POLYMERASE CHAIN REACTION; PREDICTION; PROSPECTIVE STUDY; RATING SCALE; RISK FACTOR; TAIWAN;

AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; BASE SEQUENCE; C-REACTIVE PROTEIN; COGNITION DISORDERS; CYSTATINS; DISEASE PROGRESSION; GLOMERULAR FILTRATION RATE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MENTAL STATUS SCHEDULE; MULTIVARIATE ANALYSIS; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TAIWAN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855247906     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.5975     Document Type: Article

References (20)

1. Krishnan AV, Kiernan MC. Neurological complications of chronic kidney disease. Nat Rev Neurol 5: 542-551, 2009.
2. Seliger SL, Siscovick DS, Stehman-Breen CO, et al. Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study. J Am Soc Nephrol 15: 1904-1911, 2004.
3. Buchman AS, Tanne D, Boyle PA, Shah RC, Leurgans SE, Bennett DA. Kidney function is associated with the rate of cognitive decline in the elderly. Neurology 73: 920-927, 2009.
4. Balducci L, Stanta G. Cancer in the frail patient. A coming epidemic. Hematol Oncol Clin North Am 14: 235-250, 2000.
5. Campbell KH, O'Hare AM. Kidney disease in the elderly: update on recent literature. Curr Opin Nephrol Hypertens 17: 298-303, 2008.
6. Fliser D. Assessment of renal function in elderly patients. Curr Opin Nephrol Hypertens 17: 604-608, 2008.
7. Xun L, Cheng W, Hua T, et al. Assessing glomerular filtration rate (GFR) in elderly Chinese patients with chronic kidney disease (CKD): a comparison of various predictive equations. Arch Gerontol Geriatr 51: 13-20, 2010.
8. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
9. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23: 57-63, 2000.
10. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 140: 566-572, 1982.
11. Lott R, Hayton W. Estimation of creatinine clearance from serum creatinine concentration-a review. Drug Intell Clin Pharm 12: 140-150, 1978.
12. Craft S, Cholerton B, Reger M. Cognitive changes associated with normal and pathological aging. In: Hazzard's Geriatric Medicine and Gerontology. 6th edition. McGraw-Hill, Seattle, 2009: 751-765.
13. Etgen T, Sander D, Chonchol M, et al. Chronic kidney disease is associated with incident cognitive impairment in the elderly: the INVADE study. Nephrol Dial Transplant 24: 3144-3150, 2009.
14. Euser SM, Sattar N, Witteman JC, et al. A prospective analysis of elevated fasting glucose levels and cognitive function in older people: results from PROSPER and the Rotterdam Study. Diabetes 59: 1601-1607, 2010.
15. Viles-Gonzalez JF, Fuster V, Badimon JJ. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J 25: 1197-1207, 2004.
16. Lee AJ, Fowkes FG, Lowe GD, Connor JM, Rumley A. Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study. Thromb Haemost 81: 553-560, 1999.
17. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346: 476-483, 2002.
18. Midorikawa S, Sanada H, Hashimoto S, Watanabe T. Enhancement by homocysteine of plasminogen activator inhibitor-1 gene expression and secretion from vascular endothelial and smooth muscle cells. Biochem Biophys Res Commun 272: 182-185, 2000.
19. Manoochehri M, Kamali K, Rahgozar M, Ohadi M, Farrokhi H, Khorshid HRK. Lack of Association between Tumor Necrosis Factor-alpha-308 G/A Polymorphism & Risk of Developing Late- Onset Alzheimer's Disease in an Iranian Population. Avicenna J Med Biotech 1: 193-197, 2009.
20. Walston JD. Inflammation and Aging. In: Hazzard's Geriatric Medicine and Gerontology. 6th edition. McGraw-Hill, Seattle, 2009: 37-43.